| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.8 | 0.002 | 0.8 | Acetylcholine nicotinic antagonist | 0.525 0.004 DBMET00636 | ||
| 0.764 | 0.005 | 0.764 | Spasmolytic | 0.646 0.009 DBMET00636 | ||
| 0.67 | 0.003 | 0.67 | Cholinergic antagonist | 0.381 0.009 DBMET00636 | ||
| 0.661 | 0.002 | 0.661 | Potassium channel (Ca-activated) blocker | 0.327 0.004 DBMET00636 | ||
| 0.66 | 0.004 | 0.66 | Acetylcholine antagonist | 0.379 0.009 DBMET00636 | ||
| 0.665 | 0.011 | 0.665 | Toll-Like receptor agonist | |||
| 0.656 | 0.012 | 0.656 | Toll-Like receptor 7 agonist | |||
| 0.568 | 0.002 | 0.568 | Potassium channel small-conductance Ca-activated blocker | 0.43 0.002 DBMET00636 | ||
| 0.517 | 0.053 | 0.524 | Caspase 9 stimulant | 0.524 0.051 DBMET00636 | DBMET00636 | |
| 0.477 | 0.033 | 0.534 | Vasodilator, peripheral | 0.534 0.023 DBMET00636 | DBMET00636 | |
| 0.432 | 0.018 | 0.432 | Vasodilator | 0.213 0.095 DBMET00636 | ||
| 0.387 | 0.007 | 0.387 | Anesthetic local | 0.22 0.027 DBMET00636 | ||
| 0.385 | 0.02 | 0.385 | Platelet aggregation inhibitor | |||
| 0.318 | 0.016 | 0.318 | Cholinergic | 0.304 0.018 DBMET00636 | ||
| 0.287 | 0.015 | 0.287 | Acetylcholinesterase inhibitor | 0.247 0.021 DBMET00636 | ||
| 0.306 | 0.041 | 0.323 | Psychostimulant | 0.323 0.037 DBMET00636 | DBMET00636 | |
| 0.322 | 0.076 | 0.322 | Antithrombotic | 0.256 0.121 DBMET00636 | ||
| 0.28 | 0.038 | 0.477 | Anesthetic general | 0.477 0.009 DBMET00636 | DBMET00636 | |
| 0.25 | 0.013 | 0.25 | Bronchodilator | 0.107 0.056 DBMET00636 | ||
| 0.287 | 0.051 | 0.287 | Potassium channel blocker | 0.264 0.06 DBMET00636 | ||
| 0.248 | 0.015 | 0.248 | Acetylcholine muscarinic antagonist | 0.18 0.03 DBMET00636 | ||
| 0.192 | 0.023 | 0.192 | Butyrylcholinesterase inhibitor | 0.182 0.025 DBMET00636 | ||
| 0.244 | 0.075 | 0.244 | Platelet antagonist | |||
| 0.244 | 0.074 | 0.404 | Tyrosine 3 hydroxylase inhibitor | 0.404 0.008 DBMET00636 | DBMET00636 | |
| 0.27 | 0.115 | 0.319 | Vasodilator, coronary | 0.319 0.073 DBMET00636 | DBMET00636 | |
| 0.243 | 0.088 | 0.243 | Antioxidant | 0.195 0.117 DBMET00636 | ||
| 0.309 | 0.166 | 0.309 | Apoptosis agonist | 0.254 0.21 DBMET00636 | ||
| 0.201 | 0.063 | 0.453 | P-glycoprotein inhibitor | 0.453 0.011 DBMET00636 | DBMET00636 | |
| 0.151 | 0.016 | 0.203 | Acetylcholine release stimulant | 0.203 0.005 DBMET00636 | DBMET00636 | |
| 0.165 | 0.039 | 0.165 | Nav1.3 sodium channel blocker | 0.141 0.054 DBMET00636 | ||
| 0.177 | 0.053 | 0.253 | Acetylcholine M1 receptor antagonist | 0.253 0.024 DBMET00636 | DBMET00636 | |
| 0.171 | 0.059 | 0.171 | Phospholipase A2 inhibitor | |||
| 0.143 | 0.038 | 0.143 | Expectorant | 0.119 0.051 DBMET00636 | ||
| 0.233 | 0.138 | 0.233 | Cholesterol antagonist | |||
| 0.142 | 0.047 | 0.142 | Vanilloid 1 agonist | 0.13 0.065 DBMET00636 | ||
| 0.113 | 0.028 | 0.113 | Telomerase inhibitor | |||
| 0.146 | 0.069 | 0.155 | Adenylate cyclase stimulant | 0.155 0.054 DBMET00636 | DBMET00636 | |
| 0.159 | 0.084 | 0.159 | Antipruritic | |||
| 0.1 | 0.028 | 0.107 | Acetylcholine M4 receptor antagonist | 0.107 0.024 DBMET00636 | DBMET00636 | |
| 0.165 | 0.094 | 0.165 | Hepatoprotectant | 0.154 0.106 DBMET00636 | ||
| 0.113 | 0.045 | 0.113 | Breast cancer-resistant protein inhibitor | 0.113 0.045 DBMET00636 | ||
| 0.239 | 0.174 | 0.239 | 15-Lipoxygenase inhibitor | |||
| 0.129 | 0.069 | 0.129 | Toll-Like receptor 2 antagonist | |||
| 0.089 | 0.029 | 0.379 | Neuronal nicotinic receptor antagonist | 0.379 0.004 DBMET00636 | DBMET00636 | |
| 0.157 | 0.103 | 0.237 | Amyloid beta aggregation inhibitor | 0.237 0.062 DBMET00636 | DBMET00636 | |
| 0.091 | 0.037 | 0.116 | Analgesic, opioid | 0.116 0.024 DBMET00636 | DBMET00636 | |
| 0.096 | 0.043 | 0.132 | Histamine H1 receptor antagonist | 0.132 0.029 DBMET00636 | DBMET00636 | |
| 0.077 | 0.027 | 0.077 | Acetylcholine M3 receptor antagonist | 0.063 0.037 DBMET00636 | ||
| 0.151 | 0.104 | 0.194 | Catenin beta inhibitor | 0.194 0.037 DBMET00636 | DBMET00636 | |
| 0.103 | 0.065 | 0.103 | Toll-Like receptor 4 antagonist | |||
| 0.089 | 0.053 | 0.089 | Acetylcholine M3 receptor agonist | |||
| 0.165 | 0.129 | 0.315 | Cyclic AMP phosphodiesterase inhibitor | 0.315 0.036 DBMET00636 | DBMET00636 | |
| 0.097 | 0.063 | 0.157 | Sphingomyelinase inhibitor | 0.157 0.022 DBMET00636 | DBMET00636 | |
| 0.116 | 0.082 | 0.116 | Cyclooxygenase 3 inhibitor | 0.106 0.094 DBMET00636 | ||
| 0.115 | 0.085 | 0.19 | Amylase inhibitor | 0.19 0.048 DBMET00636 | DBMET00636 | |
| 0.12 | 0.092 | 0.174 | Protein kinase stimulant | 0.174 0.053 DBMET00636 | DBMET00636 | |
| 0.101 | 0.078 | 0.101 | Platelet activating factor antagonist | |||
| 0.227 | 0.206 | 0.458 | Analgesic | 0.458 0.062 DBMET00636 | DBMET00636 | |
| 0.045 | 0.028 | 0.071 | Opioid kappa receptor agonist | 0.071 0.014 DBMET00636 | DBMET00636 | |
| 0.061 | 0.044 | 0.104 | Acetylcholine M2 receptor antagonist | 0.104 0.02 DBMET00636 | DBMET00636 | |
| 0.08 | 0.072 | 0.08 | Vanilloid agonist | |||
| 0.059 | 0.051 | 0.454 | Dopamine D1 antagonist | 0.454 0.004 DBMET00636 | DBMET00636 | |
| 0.081 | 0.076 | 0.146 | Antihistaminic | 0.146 0.033 DBMET00636 | DBMET00636 | |
| 0.046 | 0.042 | 0.083 | Nicotinic receptor alpha4 subunit antagonist | 0.083 0.012 DBMET00636 | DBMET00636 | |
| 0.084 | 0.085 | 0.097 | Toll-Like receptor 3 antagonist | 0.097 0.056 DBMET00636 | DBMET00636 | |
| 0.092 | 0.098 | 0.12 | Alkylator | 0.12 0.068 DBMET00636 | DBMET00636 | |
| 0.093 | 0.1 | 0.125 | Electron transport complex I inhibitor | 0.125 0.041 DBMET00636 | DBMET00636 | |
| 0.069 | 0.077 | 0.138 | Histamine antagonist | 0.138 0.033 DBMET00636 | DBMET00636 | |
| 0.037 | 0.045 | 0.068 | Opioid mu receptor agonist | 0.068 0.02 DBMET00636 | DBMET00636 | |
| 0.052 | 0.06 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.021 DBMET00636 | DBMET00636 | |
| 0.097 | 0.105 | 0.284 | Tubulin antagonist | 0.284 0.021 DBMET00636 | DBMET00636 | |
| 0.032 | 0.043 | 0.069 | Neurokinin 2 antagonist | 0.069 0.016 DBMET00636 | DBMET00636 | |
| 0.158 | 0.169 | 0.624 | 5 Hydroxytryptamine release stimulant | 0.624 0.012 DBMET00636 | DBMET00636 | |
| 0.076 | 0.088 | 0.226 | Prolactin inhibitor | 0.226 0.005 DBMET00636 | DBMET00636 | |
| 0.058 | 0.074 | 0.087 | Calcium channel L-type blocker | 0.087 0.033 DBMET00636 | DBMET00636 | |
| 0.222 | 0.239 | 0.378 | Calcium channel L-type activator | 0.378 0.097 DBMET00636 | DBMET00636 | |
| 0.183 | 0.205 | 0.296 | Apoptosis antagonist | 0.296 0.088 DBMET00636 | DBMET00636 | |
| 0.046 | 0.068 | 0.089 | Acetylcholine M5 receptor antagonist | 0.089 0.021 DBMET00636 | DBMET00636 | |
| 0.024 | 0.054 | 0.074 | Nicotinic receptor beta4 subunit antagonist | 0.074 0.009 DBMET00636 | DBMET00636 | |
| 0.063 | 0.093 | 0.294 | Antiadrenergic | 0.294 0.014 DBMET00636 | DBMET00636 | |
| 0.048 | 0.079 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.046 DBMET00636 | DBMET00636 | |
| 0.064 | 0.095 | 0.076 | Antineoplastic alkaloid | 0.076 0.071 DBMET00636 | DBMET00636 | |
| 0.062 | 0.093 | 0.099 | Opioid kappa receptor antagonist | 0.099 0.036 DBMET00636 | DBMET00636 | |
| 0.101 | 0.134 | 0.161 | Neurotrophic factor | 0.161 0.05 DBMET00636 | DBMET00636 | |
| 0.028 | 0.061 | 0.051 | Neurokinin 1 antagonist | 0.051 0.018 DBMET00636 | DBMET00636 | |
| 0.032 | 0.066 | 0.058 | Opioid agonist | 0.058 0.031 DBMET00636 | DBMET00636 | |
| 0.058 | 0.096 | 0.276 | Adrenaline antagonist | 0.276 0.015 DBMET00636 | DBMET00636 | |
| 0.092 | 0.133 | 0.165 | Calcium channel blocker | 0.165 0.047 DBMET00636 | DBMET00636 | |
| 0.19 | 0.23 | 0.35 | Calcium channel activator | 0.35 0.05 DBMET00636 | DBMET00636 | |
| 0.023 | 0.064 | 0.068 | Dopamine D2 agonist | 0.068 0.018 DBMET00636 | DBMET00636 | |
| 0.031 | 0.074 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DBMET00636 | DBMET00636 | |
| 0.057 | 0.101 | 0.094 | Adrenaline agonist | 0.094 0.042 DBMET00636 | DBMET00636 | |
| 0.037 | 0.085 | 0.108 | Nicotinic receptor alpha7 subunit antagonist | 0.108 0.011 DBMET00636 | DBMET00636 | |
| 0.05 | 0.1 | 0.148 | Nicotinic alpha4beta2 receptor antagonist | 0.148 0.008 DBMET00636 | DBMET00636 | |
| 0.022 | 0.071 | 0.029 | Thiazolidinedione | 0.029 0.021 DBMET00636 | DBMET00636 | |
| 0.133 | 0.183 | 0.227 | Tumour necrosis factor alpha release inhibitor | 0.227 0.088 DBMET00636 | DBMET00636 | |
| 0.03 | 0.082 | 0.062 | Neurokinin antagonist | 0.062 0.024 DBMET00636 | DBMET00636 | |
| 0.051 | 0.104 | 0.137 | Calcium antagonist | 0.137 0.027 DBMET00636 | DBMET00636 | |
| 0.077 | 0.137 | 0.131 | Microtubule formation inhibitor | 0.131 0.05 DBMET00636 | DBMET00636 | |
| 0.026 | 0.087 | 0.07 | Nicotinic receptor alpha3 subunit antagonist | 0.07 0.015 DBMET00636 | DBMET00636 | |
| 0.056 | 0.118 | 0.092 | Opioid antagonist | 0.092 0.055 DBMET00636 | DBMET00636 | |
| 0.035 | 0.099 | 0.066 | Opioid mu receptor antagonist | 0.066 0.049 DBMET00636 | DBMET00636 | |
| 0.017 | 0.08 | 0.033 | Melatonin 2 agonist | 0.033 0.022 DBMET00636 | DBMET00636 | |
| 0.167 | 0.237 | 0.253 | Sodium/bile acid cotransporter inhibitor | 0.253 0.125 DBMET00636 | DBMET00636 | |
| 0.011 | 0.083 | 0.022 | Dopamine D1 agonist | 0.022 0.018 DBMET00636 | DBMET00636 | |
| 0.051 | 0.129 | 0.093 | Acetylcholine agonist | 0.093 0.052 DBMET00636 | DBMET00636 | |
| 0.025 | 0.108 | 0.048 | Acetylcholine muscarinic agonist | 0.048 0.045 DBMET00636 | DBMET00636 | |
| 0.046 | 0.13 | 0.085 | Somatostatin 1 agonist | 0.085 0.046 DBMET00636 | DBMET00636 | |
| 0.005 | 0.091 | 0.075 | Growth hormone secretagogue receptor agonist | 0.075 0.013 DBMET00636 | DBMET00636 | |
| 0.009 | 0.095 | 0.037 | Melatonin antagonist | 0.037 0.011 DBMET00636 | DBMET00636 | |
| 0.006 | 0.095 | 0.05 | Sigma 2 receptor antagonist | 0.05 0.01 DBMET00636 | DBMET00636 | |
| 0.101 | 0.192 | 0.182 | Tumour necrosis factor antagonist | 0.182 0.066 DBMET00636 | DBMET00636 | |
| 0.063 | 0.154 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.065 DBMET00636 | DBMET00636 | |
| 0.023 | 0.116 | 0.038 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.034 DBMET00636 | DBMET00636 | |
| 0.043 | 0.14 | 0.103 | Acetylcholine nicotinic agonist | 0.103 0.035 DBMET00636 | DBMET00636 | |
| 0.043 | 0.14 | 0.499 | Alpha adrenoreceptor antagonist | 0.499 0.006 DBMET00636 | DBMET00636 | |
| 0.007 | 0.106 | 0.053 | Urotensin II antagonist | 0.053 0.006 DBMET00636 | DBMET00636 | |
| 0.007 | 0.106 | 0.018 | Melatonin 1 antagonist | 0.018 0.014 DBMET00636 | DBMET00636 | |
| 0.005 | 0.105 | 0.016 | Melatonin receptor 1A antagonist | 0.016 0.007 DBMET00636 | DBMET00636 | |
| 0.022 | 0.126 | 0.065 | Opioid delta receptor antagonist | 0.065 0.043 DBMET00636 | DBMET00636 | |
| 0.022 | 0.13 | 0.044 | GHS receptor agonist | 0.044 0.027 DBMET00636 | DBMET00636 | |
| 0.011 | 0.124 | 0.086 | Dopamine D5 antagonist | 0.086 0.011 DBMET00636 | DBMET00636 | |
| 0.098 | 0.212 | 0.431 | Aldehyde oxidase inhibitor | 0.431 0.043 DBMET00636 | DBMET00636 | |
| 0.072 | 0.188 | 0.245 | Toll-Like receptor antagonist | 0.245 0.017 DBMET00636 | DBMET00636 | |
| 0.019 | 0.136 | 0.32 | Dopamine D2 antagonist | 0.32 0.01 DBMET00636 | DBMET00636 | |
| 0.027 | 0.145 | 0.108 | Dopamine agonist | 0.108 0.024 DBMET00636 | DBMET00636 | |
| 0.012 | 0.13 | 0.062 | Neurokinin 3 antagonist | 0.062 0.018 DBMET00636 | DBMET00636 | |
| 0.039 | 0.159 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DBMET00636 | DBMET00636 | |
| 0.028 | 0.152 | 0.08 | 5 Hydroxytryptamine 1B agonist | 0.08 0.013 DBMET00636 | DBMET00636 | |
| 0.011 | 0.136 | 0.062 | Sigma receptor antagonist | 0.062 0.027 DBMET00636 | DBMET00636 | |
| 0.104 | 0.23 | 0.214 | Neurotrophic factor enhancer | 0.214 0.064 DBMET00636 | DBMET00636 | |
| 0.025 | 0.152 | 0.318 | Alpha 1 adrenoreceptor antagonist | 0.318 0.01 DBMET00636 | DBMET00636 | |
| 0.033 | 0.163 | 0.05 | Alpha 1L adrenoreceptor antagonist | 0.05 0.044 DBMET00636 | DBMET00636 | |
| 0.014 | 0.146 | 0.078 | Beta tubulin antagonist | 0.078 0.03 DBMET00636 | DBMET00636 | |
| 0.118 | 0.251 | 0.244 | Superoxide dismutase inhibitor | 0.244 0.078 DBMET00636 | DBMET00636 | |
| 0.041 | 0.177 | 0.063 | Kallikrein 7 inhibitor | 0.063 0.046 DBMET00636 | DBMET00636 | |
| 0.087 | 0.224 | 0.304 | Antimitotic | 0.304 0.043 DBMET00636 | DBMET00636 | |
| 0.03 | 0.171 | 0.055 | Antiviral (Hepatitis D) | 0.055 0.029 DBMET00636 | DBMET00636 | |
| 0.038 | 0.18 | 0.083 | Ryanodine receptor antagonist | 0.083 0.008 DBMET00636 | DBMET00636 | |
| 0.079 | 0.223 | 0.335 | Sigma receptor agonist | 0.335 0.033 DBMET00636 | DBMET00636 | |
| 0.022 | 0.172 | 0.346 | Dopamine antagonist | 0.346 0.01 DBMET00636 | DBMET00636 | |
| 0.021 | 0.173 | 0.129 | Dopamine uptake inhibitor | 0.129 0.013 DBMET00636 | DBMET00636 | |
| 0.054 | 0.209 | 0.095 | Multidrug resistance-associated protein 1 inhibitor | 0.095 0.088 DBMET00636 | DBMET00636 | |
| 0.021 | 0.179 | 0.127 | 5 Hydroxytryptamine 1F antagonist | 0.127 0.022 DBMET00636 | DBMET00636 | |
| 0.047 | 0.21 | 0.077 | Factor XII inhibitor | 0.077 0.074 DBMET00636 | DBMET00636 | |
| 0.021 | 0.185 | 0.056 | CC chemokine 4 receptor antagonist | 0.056 0.02 DBMET00636 | DBMET00636 | |
| 0.027 | 0.194 | 0.083 | 5 Hydroxytryptamine 7 agonist | 0.083 0.012 DBMET00636 | DBMET00636 | |
| 0.109 | 0.276 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.12 DBMET00636 | DBMET00636 | |
| 0.005 | 0.173 | 0.088 | Glycine transporter 1 inhibitor | 0.088 0.007 DBMET00636 | DBMET00636 | |
| 0.016 | 0.185 | 0.107 | 5 Hydroxytryptamine agonist | 0.107 0.031 DBMET00636 | DBMET00636 | |
| 0.014 | 0.185 | 0.066 | Phosphodiesterase 4A inhibitor | 0.066 0.027 DBMET00636 | DBMET00636 | |
| 0.009 | 0.183 | 0.209 | Glycine transporter inhibitor | 0.209 0.004 DBMET00636 | DBMET00636 | |
| 0.043 | 0.221 | 0.118 | Cystathionine beta-synthase inhibitor | 0.118 0.059 DBMET00636 | DBMET00636 | |
| 0.026 | 0.209 | 0.105 | Nicotinic alpha3beta2 receptor antagonist | 0.105 0.007 DBMET00636 | DBMET00636 | |
| 0.019 | 0.208 | 0.034 | Adenosine uptake inhibitor | 0.034 0.027 DBMET00636 | DBMET00636 | |
| 0.013 | 0.202 | 0.189 | Dopamine D4 antagonist | 0.189 0.013 DBMET00636 | DBMET00636 | |
| 0.016 | 0.205 | 0.061 | Phosphodiesterase 4C inhibitor | 0.061 0.034 DBMET00636 | DBMET00636 | |
| 0.021 | 0.21 | 0.067 | CXC chemokine 4 receptor antagonist | 0.067 0.038 DBMET00636 | DBMET00636 | |
| 0.011 | 0.202 | 0.041 | Dopamine D5 agonist | 0.041 0.027 DBMET00636 | DBMET00636 | |
| 0.016 | 0.208 | 0.08 | Acetylcholine M5 receptor agonist | 0.08 0.034 DBMET00636 | DBMET00636 | |
| 0.104 | 0.297 | 0.28 | Transcription factor NF kappa B inhibitor | 0.28 0.107 DBMET00636 | DBMET00636 | |
| 0.02 | 0.217 | 0.163 | Phosphodiesterase 4D inhibitor | 0.163 0.016 DBMET00636 | DBMET00636 | |
| 0.069 | 0.269 | 0.172 | DNA methyltransferase I inhibitor | 0.172 0.085 DBMET00636 | DBMET00636 | |
| 0.012 | 0.215 | 0.203 | Alpha 1a adrenoreceptor antagonist | 0.203 0.016 DBMET00636 | DBMET00636 | |
| 0.053 | 0.26 | 0.141 | Glutamate (mGluR7) agonist | 0.141 0.015 DBMET00636 | DBMET00636 | |
| 0.029 | 0.238 | 0.557 | Alpha 2 adrenoreceptor antagonist | 0.557 0.004 DBMET00636 | DBMET00636 | |
| 0.004 | 0.214 | 0.052 | 5 Hydroxytryptamine 1D agonist | 0.052 0.01 DBMET00636 | DBMET00636 | |
| 0.025 | 0.236 | 0.355 | Alpha 2a adrenoreceptor antagonist | 0.355 0.005 DBMET00636 | DBMET00636 | |
| 0.02 | 0.236 | 0.06 | Adrenaline uptake inhibitor | 0.06 0.044 DBMET00636 | DBMET00636 | |
| 0.01 | 0.232 | 0.088 | NMDA 2C receptor antagonist | 0.088 0.021 DBMET00636 | DBMET00636 | |
| 0.126 | 0.35 | 0.225 | Caspase 3 stimulant | 0.225 0.137 DBMET00636 | DBMET00636 | |
| 0.084 | 0.309 | 0.34 | Cardiotonic | 0.34 0.042 DBMET00636 | DBMET00636 | |
| 0.011 | 0.237 | 0.101 | 5 Hydroxytryptamine uptake inhibitor | 0.101 0.026 DBMET00636 | DBMET00636 | |
| 0.017 | 0.243 | 0.129 | 5 Hydroxytryptamine 2A agonist | 0.129 0.008 DBMET00636 | DBMET00636 | |
| 0.014 | 0.243 | 0.073 | Dopamine transporter inhibitor | 0.073 0.019 DBMET00636 | DBMET00636 | |
| 0.135 | 0.364 | 0.211 | Ca(v)3.3 blocker | 0.211 0.169 DBMET00636 | DBMET00636 | |
| 0.133 | 0.363 | 0.305 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 DBMET00636 | DBMET00636 | |
| 0.022 | 0.254 | 0.1 | MAO A inhibitor | 0.1 0.064 DBMET00636 | DBMET00636 | |
| 0.015 | 0.251 | 0.049 | Acid-sensing ion channel blocker | 0.049 0.017 DBMET00636 | DBMET00636 | |
| 0.008 | 0.244 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.029 DBMET00636 | DBMET00636 | |
| 0.043 | 0.285 | 0.111 | Sodium channel blocker | 0.111 0.096 DBMET00636 | DBMET00636 | |
| 0.045 | 0.305 | 0.115 | Nav1.1 sodium channel blocker | 0.115 0.052 DBMET00636 | DBMET00636 | |
| 0.012 | 0.284 | 0.156 | 5 Hydroxytryptamine 2A antagonist | 0.156 0.027 DBMET00636 | DBMET00636 | |
| 0.013 | 0.285 | 0.17 | 5 Hydroxytryptamine 1D antagonist | 0.17 0.009 DBMET00636 | DBMET00636 | |
| 0.06 | 0.334 | 0.172 | DNA methylase inhibitor | 0.172 0.099 DBMET00636 | DBMET00636 | |
| 0.103 | 0.38 | 0.225 | Insulysin inhibitor | 0.225 0.122 DBMET00636 | DBMET00636 | |
| 0.039 | 0.325 | 0.098 | Calcium channel (voltage-sensitive) blocker | 0.098 0.087 DBMET00636 | DBMET00636 | |
| 0.004 | 0.292 | 0.052 | Histamine H3 receptor antagonist | 0.052 0.025 DBMET00636 | DBMET00636 | |
| 0.031 | 0.327 | 0.367 | Toll-Like receptor 9 antagonist | 0.367 0.005 DBMET00636 | DBMET00636 | |
| 0.037 | 0.335 | 0.06 | Prolactin release inhibitor | 0.06 0.052 DBMET00636 | DBMET00636 | |
| 0.006 | 0.308 | 0.069 | 5 Hydroxytryptamine 1 agonist | 0.069 0.029 DBMET00636 | DBMET00636 | |
| 0.018 | 0.327 | 0.197 | 5 Hydroxytryptamine antagonist | 0.197 0.034 DBMET00636 | DBMET00636 | |
| 0.026 | 0.338 | 0.114 | EphA2 antagonist | 0.114 0.061 DBMET00636 | DBMET00636 | |
| 0.013 | 0.327 | 0.183 | 5 Hydroxytryptamine 2C antagonist | 0.183 0.02 DBMET00636 | DBMET00636 | |
| 0.03 | 0.346 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 DBMET00636 | DBMET00636 | |
| 0.037 | 0.354 | 0.071 | Calcium channel P-type blocker | 0.071 0.025 DBMET00636 | DBMET00636 | |
| 0.066 | 0.392 | 0.198 | ATPase inhibitor | 0.198 0.039 DBMET00636 | DBMET00636 | |
| 0.009 | 0.339 | 0.133 | 5 Hydroxytryptamine 1 antagonist | 0.133 0.027 DBMET00636 | DBMET00636 | |
| 0.028 | 0.361 | 0.227 | Alpha 2c adrenoreceptor antagonist | 0.227 0.013 DBMET00636 | DBMET00636 | |
| 0.017 | 0.354 | 0.257 | 5 Hydroxytryptamine 2 antagonist | 0.257 0.021 DBMET00636 | DBMET00636 | |
| 0.025 | 0.364 | 0.082 | Histamine H2 receptor antagonist | 0.082 0.061 DBMET00636 | DBMET00636 | |
| 0.009 | 0.351 | 0.076 | 5 Hydroxytryptamine 7 antagonist | 0.076 0.033 DBMET00636 | DBMET00636 | |
| 0.095 | 0.441 | 0.138 | Heat shock protein 70 antagonist | 0.138 0.082 DBMET00636 | DBMET00636 | |
| 0.02 | 0.375 | 0.112 | Falcipain 3 inhibitor | 0.112 0.059 DBMET00636 | DBMET00636 | |
| 0.01 | 0.367 | 0.043 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 DBMET00636 | DBMET00636 | |
| 0.005 | 0.364 | 0.182 | Alpha 1b adrenoreceptor antagonist | 0.182 0.017 DBMET00636 | DBMET00636 | |
| 0.039 | 0.4 | 0.131 | Nav1.2 sodium channel blocker | 0.131 0.071 DBMET00636 | DBMET00636 | |
| 0.097 | 0.467 | 0.166 | ErbB-1 antagonist | 0.166 0.14 DBMET00636 | DBMET00636 | |
| 0.018 | 0.39 | 0.069 | Glutamate (mGluR7) antagonist | 0.069 0.045 DBMET00636 | DBMET00636 | |
| 0.005 | 0.377 | 0.078 | 5 Hydroxytryptamine 1A antagonist | 0.078 0.041 DBMET00636 | DBMET00636 | |
| 0.042 | 0.416 | 0.176 | Antiamyloidogenic | 0.176 0.118 DBMET00636 | DBMET00636 | |
| 0.005 | 0.387 | 0.039 | 5 Hydroxytryptamine 2C agonist | 0.039 0.038 DBMET00636 | DBMET00636 | |
| 0.026 | 0.415 | 0.198 | Alpha 2b adrenoreceptor antagonist | 0.198 0.024 DBMET00636 | DBMET00636 | |
| 0.008 | 0.4 | 0.053 | Nicotinic neuronal receptor agonist | 0.053 0.042 DBMET00636 | DBMET00636 | |
| 0.009 | 0.404 | 0.125 | Phosphodiesterase IV inhibitor | 0.125 0.031 DBMET00636 | DBMET00636 | |
| 0.02 | 0.417 | 0.175 | 5 Hydroxytryptamine 2B antagonist | 0.175 0.032 DBMET00636 | DBMET00636 | |
| 0.008 | 0.412 | 0.144 | 5 Hydroxytryptamine 1B antagonist | 0.144 0.013 DBMET00636 | DBMET00636 | |
| 0.003 | 0.41 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET00636 | DBMET00636 | |
| 0.015 | 0.429 | 0.148 | Orexin receptor antagonist | 0.148 0.005 DBMET00636 | DBMET00636 | |
| 0.024 | 0.439 | 0.164 | Nav1.6 sodium channel blocker | 0.164 0.04 DBMET00636 | DBMET00636 | |
| 0.031 | 0.447 | 0.093 | Alpha 2d adrenoreceptor antagonist | 0.093 0.062 DBMET00636 | DBMET00636 | |
| 0.019 | 0.443 | 0.074 | Phosphodiesterase 1B inhibitor | 0.074 0.027 DBMET00636 | DBMET00636 | |
| 0.017 | 0.441 | 0.126 | Orexin receptor 1 antagonist | 0.126 0.005 DBMET00636 | DBMET00636 | |
| 0.016 | 0.444 | 0.062 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.042 DBMET00636 | DBMET00636 | |
| 0.014 | 0.442 | 0.059 | 5 Hydroxytryptamine 5 antagonist | 0.059 0.038 DBMET00636 | DBMET00636 | |
| 0.008 | 0.443 | 0.099 | Dopamine D3 antagonist | 0.099 0.025 DBMET00636 | DBMET00636 | |
| 0.004 | 0.443 | 0.085 | Alpha 1d adrenoreceptor antagonist | 0.085 0.028 DBMET00636 | DBMET00636 | |
| 0.003 | 0.442 | 0.089 | Orexin receptor 2 antagonist | 0.089 0.005 DBMET00636 | DBMET00636 | |
| 0.004 | 0.446 | 0.087 | 5 Hydroxytryptamine 2 agonist | 0.087 0.013 DBMET00636 | DBMET00636 | |
| 0.006 | 0.452 | 0.077 | NMDA 2B receptor antagonist | 0.077 0.022 DBMET00636 | DBMET00636 | |
| 0.004 | 0.46 | 0.035 | 5 Hydroxytryptamine 6 agonist | 0.035 0.011 DBMET00636 | DBMET00636 | |
| 0.047 | 0.518 | 0.158 | Histone acetyltransferase inhibitor | 0.158 0.128 DBMET00636 | DBMET00636 | |
| 0.03 | 0.504 | 0.113 | NADPH oxidase inhibitor | 0.113 0.092 DBMET00636 | DBMET00636 | |
| 0.002 | 0.488 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DBMET00636 | DBMET00636 | |
| 0.012 | 0.501 | 0.068 | Focal adhesion kinase 1 inhibitor | 0.068 0.065 DBMET00636 | DBMET00636 | |
| 0.045 | 0.536 | 0.219 | Hypoxia-inducible factor 1 alpha inhibitor | 0.219 0.13 DBMET00636 | DBMET00636 | |
| 0.023 | 0.523 | 0.1 | Phosphodiesterase I inhibitor | 0.1 0.045 DBMET00636 | DBMET00636 | |
| 0.006 | 0.517 | 0.072 | Alpha 1 adrenoreceptor agonist | 0.072 0.027 DBMET00636 | DBMET00636 | |
| 0.005 | 0.523 | 0.104 | Alpha adrenoreceptor agonist | 0.104 0.026 DBMET00636 | DBMET00636 | |
| 0.029 | 0.552 | 0.28 | 5 Hydroxytryptamine 1E antagonist | 0.28 0.045 DBMET00636 | DBMET00636 | |
| 0.006 | 0.572 | 0.066 | Alpha 2 adrenoreceptor agonist | 0.066 0.035 DBMET00636 | DBMET00636 | |
| 0.035 | 0.616 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.067 DBMET00636 | DBMET00636 | |
| 0.004 | 0.591 | 0.088 | 5 Hydroxytryptamine 6 antagonist | 0.088 0.019 DBMET00636 | DBMET00636 | |
| 0.008 | 0.627 | 0.099 | Nitric-oxide synthase inhibitor | 0.099 0.061 DBMET00636 | DBMET00636 | |
| 0.008 | 0.659 | 0.181 | HERG channel blocker | 0.181 0.102 DBMET00636 | DBMET00636 | |
| 0.014 | 0.67 | 0.121 | Nav1.5 sodium channel blocker | 0.121 0.053 DBMET00636 | DBMET00636 | |
| 0.009 | 0.67 | 0.198 | Potassium channel (Voltage-sensitive) blocker | 0.198 0.097 DBMET00636 | DBMET00636 | |
| 0.031 | 0.723 | 0.26 | MAP kinase 1 inhibitor | 0.26 0.222 DBMET00636 | DBMET00636 | |
| 0.014 | 0.783 | 0.36 | Antiobesity | 0.36 0.083 DBMET00636 | DBMET00636 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |